Cargando…
Remifentanil does not affect human microglial immune activation in response to pro-inflammatory cytokines
Remifentanil is a potent ultra-short acting μ-opioid analgesic drug, frequently used in anaesthesia due to its favorable pharmacodynamic and pharmacokinetic profile. It may be associated with the occurrence of hyperalgesia. Preclinical studies suggest a potential role of microglia, although the mole...
Autores principales: | Dello Russo, Cinzia, Cappoli, Natalia, Tabolacci, Elisabetta, Sollazzi, Liliana, Navarra, Pierluigi, Aceto, Paola |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Leibniz Research Centre for Working Environment and Human Factors
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201013/ https://www.ncbi.nlm.nih.gov/pubmed/37220493 http://dx.doi.org/10.17179/excli2022-5667 |
Ejemplares similares
-
The mTOR kinase inhibitor rapamycin enhances the expression and release of pro-inflammatory cytokine interleukin 6 modulating the activation of human microglial cells
por: Cappoli, Natalia, et al.
Publicado: (2019) -
The human microglial HMC3 cell line: where do we stand? A systematic literature review
por: Dello Russo, Cinzia, et al.
Publicado: (2018) -
mTOR Kinase: A Possible Pharmacological Target in the Management of Chronic Pain
por: Lisi, Lucia, et al.
Publicado: (2015) -
Perioperative analgesia in the elderly
por: Del Tedesco, Filippo, et al.
Publicado: (2023) -
Suction catheter guided insertion of ProSeal laryngeal mask airway: Experience by untrained physicians
por: Perilli, Valter, et al.
Publicado: (2014)